Vivos Therapeutics (VVOS) EBITDA Margin (2020 - 2026)
Vivos Therapeutics' (VVOS) quarterly EBITDA Margin came in at 87.81% in Q2 2026, up 3169.0% year-over-year from 2.69% in Q2 2025, and up 28.51% quarter-over-quarter from 122.84% in Q1 2026.
Powered by 
Analysis
Vivos Therapeutics (VVOS) EBITDA Margin (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported EBITDA Margin for 7 consecutive years, with 87.81% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 3169.0% year-over-year to 87.81% in Q2 2026; TTM through Jun 2026 was 104.09%, a 1007.0% decrease from a year earlier, with the FY2025 full-year figure at 110.04%, down 3905.0% from the prior year.
- EBITDA Margin was 87.81% for Q2 2026 at Vivos Therapeutics, up from 122.84% in the prior quarter.
- Over five years, EBITDA Margin peaked at 45.29% in Q2 2024 and troughed at 176.7% in Q1 2022.
- A 5-year average of 115.09% and a median of 121.86% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin soared 8481 bps in 2024 and sank 9895 bps in 2025, its largest moves.
- Over 5 years, EBITDA Margin stood at 145.9% in 2022, then increased by 17 bps to 121.09% in 2023, then jumped by 40 bps to 73.17% in 2024, then tumbled by 135 bps to 172.12% in 2025, then jumped by 49 bps to 87.81% in 2026.
- The last three EBITDA Margin figures came in at 87.81% (Q2 2026), 122.84% (Q1 2026), and 172.12% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 10.72 Bn | 9.62 Bn | 757.43 Mn | 14.58% |
| 2 | Envista Holdings | 4.22 Bn | 3.09 Bn | 407.00 Mn | 10.99% |
| 3 | Dentsply Sirona | 2.10 Bn | 1.86 Bn | 493.00 Mn | 9.13% |
| 4 | Milestone Scientific | 35.01 Mn | 32.40 Mn | 1.56 Mn | -38.30% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 3.18 Mn | 1.38 Mn | 2.95 Mn | -87.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -87.81% |
| Mar 31, 2026 | -122.84% |
| Dec 31, 2025 | -172.12% |
| Sep 30, 2025 | -63.90% |
| Jun 30, 2025 | -119.50% |
| Mar 31, 2025 | -123.28% |
| Dec 31, 2024 | -73.17% |
| Sep 30, 2024 | -65.93% |
| Jun 30, 2024 | -45.29% |
| Mar 31, 2024 | -107.78% |
| Dec 31, 2023 | -121.09% |
| Sep 30, 2023 | -107.24% |
| Jun 30, 2023 | -130.10% |
| Mar 31, 2023 | -124.58% |
| Dec 31, 2022 | -145.90% |
| Sep 30, 2022 | -122.63% |
| Jun 30, 2022 | -161.66% |
| Mar 31, 2022 | -176.70% |
| Dec 31, 2021 | -166.39% |
| Sep 30, 2021 | -118.85% |